Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
(Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to award grants to government, educational, and nonprofit entities for the purpose of supporting data collection and public health activities regarding heritable blood disorders, including sickle cell disease.
(Sec. 3) Additionally, the bill reauthorizes through FY2023 and revises the sickle cell disease grant program for federally-qualified health centers, nonprofit hospitals or clinics, and university health centers.
Became Public Law No: 115-327.
- Engrossed in Senate Formatted Text PDF Formatted XML
- Enrolled Bill Formatted Text PDF Formatted XML
- Introduced in Senate Formatted Text PDF Formatted XML
- Public Law Formatted Text PDF United States Legislative Markup
- Reported to Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2465: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-S-2465/
"S. 2465: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2465/.
S. 2465, 115th Cong. (2026), https://openamerica.io/bill/115-S-2465/.
[S. 2465: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018](https://openamerica.io/bill/115-S-2465/)